Generation Bioco Stock Total Debt
| GBIO Stock | USD 3.17 0.06 1.93% |
Generation BioCo fundamentals help investors to digest information that contributes to Generation BioCo's financial success or failures. It also enables traders to predict the movement of Generation Stock. The fundamental analysis module provides a way to measure Generation BioCo's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Generation BioCo stock.
As of the 5th of May 2024, Total Debt To Capitalization is likely to grow to 0.34. Generation | Total Debt |
Generation BioCo Company Total Debt Analysis
Generation BioCo's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Generation BioCo Total Debt | 97.89 M |
Most of Generation BioCo's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Generation BioCo is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generation Total Debt Driver Correlations
Understanding the fundamental principles of building solid financial models for Generation BioCo is extremely important. It helps to project a fair market value of Generation Stock properly, considering its historical fundamentals such as Total Debt. Since Generation BioCo's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Generation BioCo's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Generation BioCo's interrelated accounts and indicators.
Click cells to compare fundamentals
Generation Total Debt Historical Pattern
Today, most investors in Generation BioCo Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Generation BioCo's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total debt growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Generation BioCo total debt as a starting point in their analysis.
Generation BioCo Total Debt |
| Timeline |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Generation Net Debt
Net Debt |
|
Based on the latest financial disclosure, Generation BioCo has a Total Debt of 97.89 M. This is 96.44% lower than that of the Biotechnology sector and 69.86% lower than that of the Health Care industry. The total debt for all United States stocks is 98.16% higher than that of the company.
Generation BioCo is rated as one of the top companies in total debt category among related companies. Total debt of Health Care industry is currently estimated at about 97.9 Million. Generation BioCo totals roughly 97.89 Million in total debt claiming about 100% of equities under Health Care industry.Generation BioCo Current Valuation Drivers
We derive many important indicators used in calculating different scores of Generation BioCo from analyzing Generation BioCo's financial statements. These drivers represent accounts that assess Generation BioCo's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Generation BioCo's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 1.1B | 772.7M | 398.6M | 228.4M | 262.7M | 249.5M | |
| Enterprise Value | 1.1B | 709.8M | 104.3M | 216.9M | 249.5M | 237.0M |
Generation BioCo Institutional Holders
Institutional Holdings refers to the ownership stake in Generation BioCo that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Generation BioCo's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Generation BioCo's value.| Shares | Geode Capital Management, Llc | 2023-12-31 | 1.1 M | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 1.1 M | State Street Corporation | 2023-12-31 | 922 K | Ubs Group Ag | 2023-12-31 | 867.4 K | Millennium Management Llc | 2023-12-31 | 752.7 K | Renaissance Technologies Corp | 2023-12-31 | 689.4 K | Dimensional Fund Advisors, Inc. | 2023-12-31 | 683.1 K | Charles Schwab Investment Management Inc | 2023-12-31 | 381.5 K | Northern Trust Corp | 2023-12-31 | 373.1 K | T. Rowe Price Associates, Inc. | 2023-12-31 | 6.9 M | Fmr Inc | 2023-12-31 | 5.4 M |
Generation Fundamentals
| Return On Equity | -0.52 | ||||
| Return On Asset | -0.23 | ||||
| Operating Margin | (13.35) % | ||||
| Current Valuation | 44.26 M | ||||
| Shares Outstanding | 66.49 M | ||||
| Shares Owned By Insiders | 14.48 % | ||||
| Shares Owned By Institutions | 79.96 % | ||||
| Number Of Shares Shorted | 1.58 M | ||||
| Price To Book | 1.21 X | ||||
| Price To Sales | 41.66 X | ||||
| Revenue | 5.9 M | ||||
| EBITDA | (133.3 M) | ||||
| Net Income | (126.61 M) | ||||
| Cash And Equivalents | 301.17 M | ||||
| Cash Per Share | 5.07 X | ||||
| Total Debt | 97.89 M | ||||
| Debt To Equity | 0.27 % | ||||
| Current Ratio | 17.93 X | ||||
| Book Value Per Share | 3.07 X | ||||
| Cash Flow From Operations | (52.74 M) | ||||
| Short Ratio | 6.33 X | ||||
| Earnings Per Share | (1.96) X | ||||
| Target Price | 7.5 | ||||
| Number Of Employees | 174 | ||||
| Beta | 2.79 | ||||
| Market Capitalization | 210.77 M | ||||
| Total Asset | 374.76 M | ||||
| Retained Earnings | (571.38 M) | ||||
| Working Capital | 232.7 M | ||||
| Net Asset | 374.76 M |
About Generation BioCo Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Generation BioCo's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Generation BioCo using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Generation BioCo based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Generation BioCo Piotroski F Score and Generation BioCo Altman Z Score analysis. To learn how to invest in Generation Stock, please use our How to Invest in Generation BioCo guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for Generation Stock analysis
When running Generation BioCo's price analysis, check to measure Generation BioCo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Generation BioCo is operating at the current time. Most of Generation BioCo's value examination focuses on studying past and present price action to predict the probability of Generation BioCo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Generation BioCo's price. Additionally, you may evaluate how the addition of Generation BioCo to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is Generation BioCo's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Generation BioCo. If investors know Generation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Generation BioCo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.96) | Revenue Per Share 0.092 | Return On Assets (0.23) | Return On Equity (0.52) |
The market value of Generation BioCo is measured differently than its book value, which is the value of Generation that is recorded on the company's balance sheet. Investors also form their own opinion of Generation BioCo's value that differs from its market value or its book value, called intrinsic value, which is Generation BioCo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Generation BioCo's market value can be influenced by many factors that don't directly affect Generation BioCo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Generation BioCo's value and its price as these two are different measures arrived at by different means. Investors typically determine if Generation BioCo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Generation BioCo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.